购物车
- 全部删除
- 您的购物车当前为空
CRM1-IN-2(Compound KL2)为非共价CRM1抑制剂,能够定位CRM1于核外围,耗尽核内CRM1,从而抑制CRM1介导的核输出。该化合物能抑制结直肠癌细胞的生长并诱导细胞凋亡(apoptosis)。
CRM1-IN-2(Compound KL2)为非共价CRM1抑制剂,能够定位CRM1于核外围,耗尽核内CRM1,从而抑制CRM1介导的核输出。该化合物能抑制结直肠癌细胞的生长并诱导细胞凋亡(apoptosis)。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 询价 | 期货 | |
50 mg | 询价 | 期货 |
产品描述 | CRM1-IN-2 (Compound KL2) is a noncovalent inhibitor that targets CRM1, localizing it to the nuclear periphery, depleting its nuclear presence, and inhibiting its nuclear export function. It demonstrates the capability to inhibit the growth of colorectal cancer cells and induce apoptosis [1]. |
分子量 | 504.7 |
分子式 | C29H48N2O5 |
存储 | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容